Cytogenetic and histologic correlation of peripheral nerve sheath tumors of soft tissue

Cancer Genetics and Cytogenetics

Volumn 88, Issue 1, 1996, Pages 17-25

  Rao, Uma N M ^a   Surti, Urvashi ^a,b   Hoffner, Lori ^b   Yaw, Kenneth ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME 1; CHROMOSOME 17Q; CHROMOSOME 2; CHROMOSOME 22Q; CHROMOSOME 7; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MALE; MALIGNANT NEURILEMOMA; NERVE SHEATH TUMOR; NEUROFIBROMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; SEX CHROMOSOME; SOFT TISSUE TUMOR;

EID: 0029994338     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-4608(95)00281-2     Document Type: Article

References (46)

1. Fletcher CDM, Davies SE (1986): Benign plexiform (multinodular) schwannoma: A rare tumour unassociated with neurofibromatosis. Histopathology 10:971-980.
2. Iwashita T, Enjoji M (1987): Plexiform neurofibroma: a clinicopathological and immunohistochemical analysis of 23 tumors from 20 patients. Virchows Arch A Pathol Anat Histopathol 411:305-309.
3. Enzinger FM, Weiss S (1995): Soft tissue tumours, 2nd Edition. The CV Mosby Company Publishers, p. 837.
4. Woodruff JM, Godwin TA, Erlandson RA, Susin M, Martin N (1981): Cellular schwannoma. A variety of schwannoma mistaken for a malignant tumor. AJCP 5:733-744.
5. Harkin JC, Reed RJ (1969): Tumors of the peripheral nervous system. AFIP Fascicle 3:107-136.
6. Rasbridge SA, Browse NL, Tighe JR, Fletcher CDM (1989): Malignant nerve sheath tumour arising in a benign ancient schwannoma. Histopathology 14:525-528.
7. Hope DG, Mulvihill JJ (1981): Malignancy in neurofibromatosis in Riccardi VM, Mulvhill JJ, eds. Advances in neurology, Vol 29, Neurofibromatosis (von Recklinghausen's Disease). New York, Raven Press, pp. 33-56.
8. Schmidt MA, Michels VV, Dewald GW (1987): Cases of neurofibromatosis with rearrangement of chromosome 17 involving band 17q11.2. Am J Med Genet 28:771-777.
9. Cawthon RM, Weiss R, Xu G, Viskochill D, Culver M, Stevens J, Robertson M, Dunn D, Gesteland R, O'Connell P, White R (1990): A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure and point mutation. Cell 62:193-210.
10. Wallace MR, Marchuk DA, Andersen LB, Letcher R, Oden HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL, Brownstein BH, Collins FS (1990): Type 1 neurofibromatosis gene: identification of a large transcript disrupted in 3 NF1 patients. Science 249:181-186.
11. Viskochill D, Buchberg AM, Xu C, Cawthorn RM, Stevens J, Wolff RK, Culver M, Carey JC, Copelenad, Jenkins NA, White R, O'Connell P (1990): Deletions of a translocation interrupt a cloned gene at NF type 1 locus. Cell 62:187-192.
12. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B, Pulst B, Lenoir G, Bijlsma E, Fashold R, Dumanski J, dejong P, Parry D, Eldrige R, Aurias A, Delattre O, Thomas G (1993): Alteration in a new gene encoding a putative membrane organizing protein causes neurofibromatosis type 2. Nature 363:515-521.
13. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Hease VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ, Gusella JF (1993): A novel Moesin-Ezrin-Radixin-like gene is a candidate for the NF2 tumor suppressor. Cell 72:791-800.
14. Stenman G, Kindblom L-G, Johansson M, Angervall L (1991): Clonal chromosome abnormalities and in vitro growth characteristics of classical and cellular schwannomas. Cancer Genet Cytogenet 57:121-131.
15. Bijlsma EK, Brouwer-Mladin R, Bosch DA, Westerveld A, Hulsebos T (1992): Molecular characteristics of chromosome 22 deletion in schwannoma. Genes Chrom Cancer 5:201-205.
16. Krone W, Hogemann I (1986): Cell culture studies on neurofibromatosis (Von Recklinghausen). Monosomy 22 and other chromosomal anomalies in cultures from peripheral neurofibromas. Hum Genet 74:453-455.
17. Fontaine B, Hanson MP, VonSattel JP, Martuza RL, Gusella JF (1991): Loss of chromosome 22 alleles in human sporadic spinal schwannomas. Ann Neurol 29:183-186.
18. Fontaine B, Rouleau GA, Seizinger BR, Menon AG, Jewell AF, Martuza RL, et al (1991): Molecular genetics of neurofibromatosis 2 and related tumors. (Acoustic Neuroma and Meningioma). Ann NY Acad Sci 615:338-343.
19. Rey JA, Bello MJ, de Campos JM, Benitez J, Sarasa JL, Boixados JR, Cascos AS (1987): Cytogenetic clones in a recurrent neurofibroma. Cancer Genet Cytogenet 26:157-165.
20. Wolff RK, Frazer KA, Jackler RK, Lanser MJ, Pitts H, Cox D (1992): Analysis of chromosome 22 deletions in neurofibromatosis type 2 related tumors. Am J Hum Genet 51:478-485.
21. Couturier J, DeLattre O, Kujas M, Philippon J, Peter M, Rouleau G, Aurias A, Thomas G (1990): Assessment of chromosome 22 anomalies in neuromas by combined karyotype and RFLP analysis. Cancer Genet Cytogenet 45:55-62.
22. Rey JA, Bello MJ, Kusak ME, deCampos JM, Pestana A (1993): Involvement of 22q12 in a neurofibrosarcoma in NF Type 1. Cancer Genet Cytogenetics 66:28-32.
23. Menon AG, Anderson KM, Riccardi VM, Chung RY, Whaley JM, Yandell DW, Farmer GE, Freiman RN, Lee JK, Li FP, Barker DF, Ledbetter DH, Kleider A, Martuza RL, Gusella JF, Seizinger BR (1990): Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci USA 87:5435-5439.
24. Lothe RA, Saeter G, Danielsen HE, Stenwig B, Hoyheim B, O'Connell P, Borrensen A-L (1993): Genetic alterations in malignant schwannoma from patient with neurofibromatosis (NF1). Path Res Practice 189:465-471.
25. Reynolds JE, Fletcher JA, Lytle OH, Li N, Morton CC, Diehl SR (1992): Molecular characterization of a 17q11.2 translocation in a malignant schwannoma cell line. Hum Genet 90:450-456.
26. Glover TW, Stein CK, Legius E, Andersen LB, Brereton A, Johnson S (1991): Molecular and cytogenetic analysis of tumors in Von Recklinghausen neurofibromatosis. Genes Chrom Cancer 3:62-70.
27. Riccardi VM, Elder DW (1986): Multiple cytogenetic aberrations in neurofibrosarcomas complicating neurofibromatosis. Cancer Genet Cytogenet 23:199-209.
28. Valdueza JM, Hagel C, Westphal M, Hansel M, Herrmann HD (1991): Primary spinal malignant schwannoma: clinical histological and cytogenetic findings. Neurosurg Rev 14:283-291.
29. Decker HJ, Cannizzaro LA, Mendez MJ, Leong SPL, Bixenman M, Berger C, Sandberg AA (1990): Chromosomes 17 & 22 involved in marker formation in neurofibrosarcoma in von Recklinghausen disease. Hum Genet 85:337-342.
30. ISCN (1991): Guidelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. F. Mitelman, ed. S. Karger, Basel.
31. Shiraki M, Enterline MT, Brooks JJ, Cooper NS, Hirchel S, Roth JA, Rao UN, Enzinger FM, Amato DA, Borden EC (1989): Pathologic analysis of advanced soft tissue sarcomas, bone sarcomas and mesotheliomas. The ECOG Experience. Cancer 64:484-490.
32. Johnson MD, Click AD, Davis BW (1988): Immunohistochemical evaluation of leu-7, MBP, S-100, GFAP, tLN3 immunoreactivity in nerve sheath tumours and schwannomas. Arch Pathol Lab Med 112:155-160.
33. Giangaspero F, Fratamico FC, Ceccarelli C, Brisigotti M (1989): Malignant peripheral nerve sheath tumors and spindle cell sarcomas. An immunohistochemical analysis of multiple markers. Appl Pathol 7:134-144.
34. de Jong KP, Vuzevski VD, Eggermont AM, Jeekel J (1990): Solitary malignant schwannoma: Clinical aspects, immunohistochemistry and ultrastructure. Eur J Surg Oncol 16:229-236.
35. Gray MM, Rosenberg AE, Dickersin RG, Bhan AK (1989): Glial fibrillary acid protein and keratin expression in benign and malignant nerve sheath tumors. Hum Pathol 20:1089-1096.
36. Lodding P, Kindblom L-G, Angervall L, Stenman G (1990): Cellular schwannoma. A clinicopathologic study of 29 cases. Virchows Arch A Pathol Anat Histopathol 416:237-248.
37. White W, Shiu MH, Rosenblum MK, Erlandson RA, Woodruff JM (1990): Cellular schwannoma. A clinicopathologic study of 57 patients and 58 tumors. Cancer 66:1266-1275.
38. Fletcher CD, Davies SE, McKee PH (1987): Cellular schwannoma: a distinct pseudosarcomatous entity. Histopathology 11:21-35.
39. Ducatman BA, Scheithauer BW, Piepgras DG, Reiman MM, llstrup DM (1986): Malignant PNET, a clinicopathologic study of 120 cases. Cancer 57:2006-2021.
40. Russell DS, Rubinstein LJ (1989): Pathology of Tumors of the Nervous System. 5th Edition, Baltimore, Williams and Wilkins Publishers.
41. Seppala MT, Haltia MJ (1993): Spinal malignant nerve sheath tumors or cellular schwannoma. A striking difference in prognosis. J Neurol 79:528-532.
42. Hadju S (1993): Editorial: peripheral nerve sheath tumours, histogenesis, classification and prognosis. Cancer 72:3459-3462.
43. Skuse GR, Kosciolek BA, Rowley PT (1991): The neurofibroma of von Recklinghausen neurofibromatosis has a unicellular origin. Am J Hum Genet 49:600-607.
44. Bijlsma EK Merel P, Bosch DA, Westerveld A, Delattre C, Thomas G, Hulsebos TJM (1994): Analysis of mutations in the SCH gene in schwannomas. Genes Chrom Cancer 11:7-14.
45. Twist EC, Ruttledge MH, Rousseau UM, Sanson M, Papi L, Merel P, Delattre O, Thomas G, Rouleau GA (1994): NF2 gene is inactivated in schwannomas. Hum Mol Genet 3:147-151.
46. Travis JA Sandberg AA, Neff JR, Bridge JA (1994): Cytogenetic findings in malignant Triton tumors. Genes Chrom Cancer 9:1-7.